Plasma tumor necrosis factor-α soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women

Journal of Reproductive Immunology

Volumn 40, Issue 2, 1998, Pages 159-173

  Williams, Michelle A ^a,b,c   Mahomed, Kassam ^d   Farrand, Allen ^b   Woelk, Godfrey B ^d   Mudzamiri, Sarah ^d   Madzime, Simon ^d   King, Irena B ^b   McDonald, George B ^b  

^a SWEDISH MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Cytokines; Preeclampsia; Pregnancy; Soluble receptor; Tumor necrosis factor 1

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; ECLAMPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; ZIMBABWE;

ANTIGENS, CD; CASE-CONTROL STUDIES; ECLAMPSIA; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; ZIMBABWE;

EID: 0032213893     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(98)00074-6     Document Type: Article

References (43)

1. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D., Kufhtai, G., 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51, 5602-5607.
2. Antin, J.H., Ferrara, J.L.M., 1992. Cytokine dysregulation and acute graft-versus-host disease. Blood 80, 2964-2986.
3. Bazzoni, F., Beutler, B., 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334, 1717-1725.
4. Caughey, G.E., Mantzioris, E., Gibson, R.A., Gleland, L.G., James, M.J., 1996. The effects of human tumor necrosis factor a and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 63, 116-122.
5. Chen, G., Wilson, R., Wang, S.H., Zheng, H.Z., Walker, J.J., McKillop, J.H., 1996. Tumour necrosis factor-alpha (TNF-α) gene polymorphism and expression of pre-eclampsia. Clin. Exp. Immunol. 104, 154-159.
6. Conrad, K.P., Benyo, D.F., 1997. Placental cytokines and the pathogenesis of preeclampsia. Am. J. Rep. Immunol. 37, 240-249.
7. Feingold, K.R., Serio, M.K., Adi, S., Moser, A.M., Grunfeld, C., 1989. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 124, 2336-2342.
8. Fiers, W., 1991. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. Fed. Eur. Biochem. Soc. 285, 199-212.
9. Gedeit, R.G., 1996. Tumor necrosis factor-induced E-selectin expression on vascular endothelial cells. Crit. Care Med. 24, 1543-1546.
10. Godfried, M., van der Poll, T., Jensen, J., Romijin, J., Sochattenker, J., Endert, E., von Deventer, F., Sauerwein, H., 1993. Soluble receptors for tumor necrosis factor: a putative marker of disease progression in HIV infection. A.I.D.S. 7, 33-36.
11. Gratacos, E., Casals, E., Sanllehy, C., Cararach, V., Alonso, P.L., Fortuuny, A., 1996. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta. Obstet. Gynecol. Scand. 75, 896-901.
12. Greenland, S., 1989. Modeling and variable selection in epidemiologic analysis. Am. J. Publ. Health 79, 340-349.
13. Greer, I.A., Haddad, N.G., Dawes, J., Johnstone, F.D., Calder, A.A., 1989. Neutrophil activation in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol. 96, 978-982.
14. Greer, I.A., Lyall, F., Perera, T., Boswell, F., Macara, L.M., 1994. Increased concentration of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet. Gynecol. 84, 937-940.
15. Habib, F.M., Springall, D.R., Davies, G.J., Oakley, C.M., Yacoub, M.H., Polak, J.M., 1996. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347, 1151-1155.
16. Hamai, Y., Fujii, T., Yamashita, T., Nishina, H., Kozuma, S., Mikami, Y., Taketani, Y., 1997. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestation of preeclampsia. Am. J. Reprod. Immunol. 38, 89-93.
17. Hsieh, C.C., Maisonneuve, P., Boyle, P., Macfarlane, G.J., Robertson, C., 1991. Analysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases or all subjects. Epidemiology 2, 137-140.
18. Hunt, J.S., 1989. Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells. J. Reprod. Immunol. 16, 1-17.
19. Hunt, J.S., Chen, H.-L., Miller, L., 1996. Tumor necrosis factors: pivotal components of pregnancy. Biol. Repro. 54, 554-562.
20. Kaaja, R., Tikkanen, M.J., Vinnikka, L., Ylikorkala, O., 1995. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol. 85, 353-356.
21. Kupfermine, M.J., Peaceman, A.M., Wigton, T.R., Rehnberg, K.A., Socol, M.L., 1994. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am. J. Obstet. Gynecol. 170, 1752-1759.
22. Mantel, N., 1963. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J. Am. Stat. Assoc. 58, 690-700.
23. Meydani, S.N., Dinarello, C.A., 1993. Influences of dietary fatty acids on cytokine production and its clinical implications. Nutr. Clin. Practice 8, 65-72.
24. Orvieto, R., Ben-Rafael, Z., 1994. The role of cytokines in early detection of preeclampsia. Med. Hypotheses. 43, 315-318.
25. Parson, P.E., Moore, F.A., Moore, E.E., Ikle, D.E., Henson, P.M., Worthen, G.S., 1992. Studies of the role of tumor necrosis factor in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 146, 694-700.
26. Perlmutter, D.H., Dinarello, C.A., Punsal, P.I., Colten, H.R., 1986. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J. Clin. Invest. 78, 1349-1354.
27. Peristeris, P., Clark, B.D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., Orencole, S.F., Sironi, M., Ghezzi, P., 1992. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell. Immunol. 140, 390-399.
28. Potter, J.M., Nestel, P.J., 1979. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am. J. Obstet. Gynecol. 15, 165-170.
29. Redman, C.W.G., 1997. Cytotrophoblasts: masters of disguise. Nat. Med. 3, 610-611.
30. Roberts, J.M., Redman, C.W.G., 1993. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341, 1447-1451.
31. Rose, H.G., Oklander, M., 1965. Improved procedure for the extraction of lipids from human erythrocytes. J. Lipid Res. 6, 428-431.
32. Rothman, K., 1986. Modern Epidemiology. Little Brown, Boston.
33. Stark, J.M., 1993. Pre-eclampsia and cytokine induced oxidative stress. Br. J. Obstet. Gynaecol. 100, 105-109.
34. Starnes, Jr., H.F., Warren, R.S., Jeevanandem, M., Gabrilov, J.L., Larchian, W., Oettgen, H.F., Brennan, M.F., 1988. Tumor necrosis factor and the acute metabolic response to injury in man. J. Clin. Invest. 82, 1321-1325.
35. Taylor, R.N., 1997. Review: immunobiology of preeclampsia. Am. J. Reprod. Immunol. 37, 79-86.
36. Todt, J.C., Yang, Y., Lei, J., Lauria, M.R., Sorokin, Y., Cotton, D.B., Yelian, F.D., 1996. Effects of tumor necrosis factor-alpha on human trophoblast cell adhesion and motility. Am. J. Reprod. Immunol. 36, 65-71.
37. van der Poll, T., Buller, H., ten Cate, H., Wortel, C.H., Bauer, K.A., van Devenster, S.J., Hack, C.E., Sauerwein, H.P., Rosenberg, R.D., ten Cate, J.W., 1990. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N. Engl. J. Med. 332, 1622-1627.
38. Vince, G.S., Starkey, P.M., Austgulen, R., Kwiatkowski, D., Redman, C.W.G., 1995. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br. J. Obstet. Gynaecol. 102, 20-25.
39. Visser, W., Beckmann, I., Bremer, H.A., Lim, H.L., Wallenburg, H.C.S., 1994. Bioactive tumour necrosis factor α in pre-eclamptic patients with and without the HELLP syndrome. Br. J. Obstet. Gynaecol. 101, 1081-1082.
40. Wang, Y., Walsh, S.W., 1996. TNF-α concentrations and mRNA expression are increased in preeclamptic placentas. J. Reprod. Immunol. 32, 157-169.
41. Williams, M.A., Zingheim, R.W., King, I.B., Zebelman, A.M., 1995. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 6, 232-237.
42. Zhang, J., Zeisler, J., Hatch, M.C., Berkowitz, G., 1997. Epidemiology of pregnancy-induced hypertension. Epidemiol. Rev. 19, 218-232.
43. Zuspan, F.P., Samuels, P., 1993. Preventing preeclampsia. N. Engl. J. Med. 329, 1265-1266.